Diagonal Bio AB (publ) (NGM:DIABIO)

Diagonal Bio AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.82	2.97	13.59	20.77	3.67
Cash & Short-Term Investments	0.82	2.97	13.59	20.77	3.67
Cash Growth	-72.48%	-78.12%	-34.58%	466.14%	-
Accounts Receivable	-	0.02	-	0.19	-
Other Receivables	0.2	0.5	0.68	0.28	0.3
Receivables	0.2	0.52	0.68	0.47	0.3
Inventory	0.55	1.03	-	-	-
Prepaid Expenses	0.2	0.21	0.23	0.21	0.03
Other Current Assets	0.83	-	-	-	-
Total Current Assets	2.6	4.73	14.5	21.44	3.99
Property, Plant & Equipment	0.01	0.02	-	-	-
Other Intangible Assets	3.4	2.88	1.78	0.33	-
Long-Term Deferred Charges	21.12	20.87	17.74	14.24	5.98
Total Assets	27.13	28.51	34.03	36.01	9.97
Accounts Payable	0.44	1.91	1.61	0.58	0.96
Accrued Expenses	0.4	1	0.83	0.78	0.08
Current Unearned Revenue	-	-	-	0.2	-
Other Current Liabilities	1.7	4.35	0.34	0.58	0.04
Total Current Liabilities	2.54	7.26	2.78	2.14	1.08
Other Long-Term Liabilities	-	0	-0	-	-
Total Liabilities	2.54	7.26	2.78	2.14	1.08
Common Stock	4	4	3.48	0.92	0.03
Additional Paid-In Capital	52.49	57.25	56.18	45.2	9.44
Retained Earnings	-31.9	-40	-28.41	-12.25	-0.58
Comprehensive Income & Other	0	-	-	-	0.01
Shareholders' Equity	24.6	21.25	31.25	33.87	8.89
Total Liabilities & Equity	27.13	28.51	34.03	36.01	9.97
Net Cash (Debt)	0.82	2.97	13.59	20.77	3.67
Net Cash Growth	-72.48%	-78.12%	-34.58%	466.14%	-
Net Cash Per Share	0.00	0.08	1.43	3.02	1.05
Filing Date Shares Outstanding	400.71	39.98	34.77	9.15	2.15
Total Common Shares Outstanding	400.71	39.98	34.77	9.15	2.15
Working Capital	0.07	-2.53	11.72	19.29	2.92
Book Value Per Share	0.06	0.53	0.90	3.70	4.14
Tangible Book Value	21.2	18.37	29.47	33.53	8.89
Tangible Book Value Per Share	0.05	0.46	0.85	3.67	4.14

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.